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Inhibition of 241 -sterol methyltransferase (24-SMT) in Sporothrix schenckii sensu stricto
and Sporothrix brasiliensis was investigated in vitro. The effects on fungal growth
and sterol composition of the 24-SMT inhibitor 22-hydrazone-imidazolin-2-yl-chol-
5-ene-3β-ol (H3) were compared to those of itraconazole. MIC and MFC analysis
showed that H3 was more effective than itraconazole against both species in both
their filamentous and yeast forms. H3 showed fungistatic activity in a time-kill assay,
with inhibitory activity stronger than that of itraconazole. GC analysis of cell sterol
composition showed that sterols present in control cells (ergosterol and precursors)
were completely replaced by 14α-methylated sterols after H3 exposure. Itraconazole
only partially inhibited ergosterol synthesis but completely arrested synthesis of other
sterols found in control cells, promoting accumulation of nine 14α-methyl sterols. Based
on these results, we propose a schematic model of sterol biosynthesis pathways in
S. schenckii and S. brasiliensis. Effects on cell morphology due to 24-SMT inhibition by
H3 as analyzed by SEM and TEM included irregular cell shape, reduced cytoplasmic
electron-density, and reduced thickness of the microfibrillar cell wall layer. Moreover,
24-SMT inhibition by H3 promoted mitochondrial disturbance, as demonstrated by
alterations in MitoTrackerr Red CMXRos fluorescence intensity evaluated by flow
cytometry. When used in conjunction with itraconazole, H3 enhanced the effectiveness
of itraconazole against all tested strains, reducing at least half (or more) the MIC values of
itraconazole. In addition, cytotoxicity assays revealed that H3 was more selective toward
these fungi than was itraconazole. Thus, 24-SMT inhibition by H3 was an effective
antifungal strategy against S. schenckii and S. brasiliensis. Inhibition of the methylation
reaction catalyzed by 24-SMT has a strong antiproliferative effect via disruption of
ergosterol homeostasis, suggesting that this enzyme is a promising target for novel
antifungal therapies against sporotrichosis, either as sole treatments or in combination
with itraconazole.
Keywords: Sporothrix schenckii, Sporothrix brasiliensis, 124-sterol methyltransferase, sterol biosynthesis,
antifungal activity
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INTRODUCTION
In the last decade, the incidence of sporotrichosis, a subcutaneous
mycosis with worldwide distribution, has increased in Brazil
(Chakrabarti et al., 2015), particularly in the state of Rio
de Janeiro (Silva et al., 2012). Moreover, reports of more
severe forms of the disease have become increasingly frequent
(Almeida-Paes et al., 2014).
Sporotrichosis is caused by dimorphic fungi from the
Sporothrix schenckii complex (Marimon et al., 2007), with
Sporothrix schenckii sensu stricto and Sporothrix brasiliensis
representing the most common clinically isolated forms in Brazil
(Rodrigues et al., 2014b) and the most virulent species infecting
animal models (Arrigala-Moncrieff et al., 2009; Fernandes et al.,
2013). In particular, S. brasiliensis is epidemic and responsible
for human and feline sporotrichosis cases in the state of Rio de
Janeiro, Brazil (Rodrigues et al., 2013).
Itraconazole is the first-choice treatment for cutaneous
and lymphocutaneous sporotrichosis (Kauffman et al., 2007).
This azole compound inhibits ergosterol biosynthesis at the
C14α-demethylation stage (Odds et al., 2003) that is catalyzed
by the cytochrome P-450-dependent 14α-demethylase. The
resulting ergosterol depletion, with the accumulation of
14α-methylated sterols, interferes with the architecture and
fluidity of fungal membranes, which can no longer act as
permeability barriers (Odds et al., 2003).
Finding new and more effective agents to treat sporotrichosis
is imperative, given the increased incidence and the limitations
of the current therapy (itraconazole), which include: (i) the need
for long and costly periods of treatment; (ii) the severity of side
effects (Kauffman et al., 2007), and (iii) the emergence of isolates
with low susceptibility to itraconazole in vitro (Rodrigues et al.,
2014a; Borba-Santos et al., 2015).
Research efforts have investigated metabolic pathways of
pathogenic organisms to find sensitive fungal targets. The
search for compounds selective against protozoa and fungi
and which spare mammalian cells has led to the development
of inhibitors of ergosterol biosynthesis other than at the
C14α-demethylase stage. Particular attention has been given
to inhibitors of 124-sterol methyltransferase (24-SMT; an
enzyme of ergosterol biosynthesis restricted to plants, protozoa,
and fungi) that have shown antimicrobial effects against
protozoa and fungi (de Souza and Rodrigues, 2009). However,
modulation of 24-SMT activity in Sporothrix sp. has not been
investigated.
The aim of this study was to determine the effects of 24-
SMT inhibition on growth of S. schenckii sensu stricto (described
as S. schenckii) and S. brasiliensis and on sterol composition
in these fungal species. For this purpose, we used the 24-
SMT inhibitor 22-hydrazone-imidazolin-2-yl-chol-5-ene-3β-ol
(H3; Figure 1). H3 was chosen as it has previously been described
as exhibiting anti-proliferative activity against the dimorphic
fungus Paracoccidioides brasiliensis (Visbal et al., 2011) and the
yeasts Candida albicans and Cryptococcus neoformans (Vivas
et al., 2011). Additionally, we compared the effect of H3 to that
of itraconazole. We found that inhibition of 24-SMT by H3
completely depleted ergosterol in S. schenckii and S. brasiliensis,
FIGURE 1 | Molecular structure of the 124-sterol methyltransferase
(24-SMT) inhibitor H3.
whereas itraconazole only partially blocked its synthesis, pointing
to the importance of this enzyme in Sporothrix sp. metabolism.
MATERIALS AND METHODS
Fungal Isolates
A total of 32 isolates were used to evaluate the effect of the 24-
SMT inhibitor H3: 16 Sporothrix schenckii sensu stricto (described
here only as S. schenckii) isolates (ATCC MYA 4820, ATCC MYA
4821, ATCC 32286, ATCC 16345, Ss-B02, BH1, Ss-B01, Ss 03,
Ss 17, Ss 22, Ss 42, Ss 59, Ss 73, Ss116, Ss 119, and Ss 144)
and 16 Sporothrix brasiliensis isolates (ATCC MYA 4822, ATCC
MYA 4823, FMR 8337, Ss 07, Ss 14, Ss 34, Ss 37, Ss 52, Ss
54, Ss 56, Ss 57, Ss 59, Ss 68, Ss 69, Ss 72, and Ss 81), all of
which had been previously classified by genotypic identification
(Castro et al., 2013; Rodrigues et al., 2013; Borba-Santos et al.,
2015). Fungal isolates were stored in potato dextrose agar (PDA;
Difco, Detroit, MI, USA) plates at 4◦C. For microdilution tests,
each strain was grown in the filamentous form in PDA medium
at 35◦C for 7 days, and the yeast phase was obtained by two
successive passages on brain heart infusion broth (Difco, Detroit,
MI, USA) supplemented with 2% glucose and incubated at 36◦C
with orbital agitation (150 rpm) for 7 days.
Drugs
22-hydrazone-imidazolin-2-yl-chol-5-ene-3β-ol (H3) (Figure 1)
was synthesized as previously described by Visbal et al. (2011).
Itraconazole (Sigma Chemical Co., Saint Louis, MO, USA) was
used as a reference antifungal. All drugs were diluted in DMSO
to obtains stock solution of 1600 mg/L, and stock solutions were
kept at−20◦C.
Antifungal Activity Assays
Microdilution methods based on those found in Clinical and
Laboratory Standards Institute (CLSI) documents M27-A3 (yeast
form; CLSI, 2008a) and M38-A2 (filamentous form; CLSI, 2008b)
and previously described by Borba-Santos et al. (2015) were used
to determine the minimum inhibitory concentrations (MIC) of
both H3 and itraconazole. The MIC was defined as the lowest
concentration of antifungal that inhibits fungal growth relative
to untreated controls, as determined by visual inspection in an
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inverted light microscope, after 5 days of incubation at 35◦C in
the dark in a humid chamber with 5% CO2. Minimum fungicidal
concentration (MFC) was determined by plating 10-µL aliquots
of fungal samples (from MIC experiments) that had been treated
with drug concentrations higher than the MIC onto drug-free
PDA plates, which were then incubated at 35◦C for 7 days. The
MFC was considered the lowest drug concentration that failed to
produce fungal growth after 7 days of growth on drug-free PDA.
Time-Kill Assay and Growth Parameter
Determination
Sporothrix schenckii strain ATCC MYA 4821 and S. brasiliensis
strain ATCC MYA 4823, two isolates that had been used in a
comparative genomics study (Teixeira et al., 2014) and which will
be referred to henceforth as S. schenckii 4821 and S. brasiliensis
4823, were used as representatives of the two species in time-kill
assays as well as in all subsequent experiments. Yeast cells (103
cells/mL) were incubated with 4xMIC or 8xMIC concentrations
of itraconazole or H3 in RPMI 1640 medium supplemented with
2% glucose and buffered to pH 7.2 with 0.165 M MOPS for
24, 48, 72, 96, or 168 h at 35◦C, after which a 50-µL aliquot
of diluted culture was plated on PDA medium and incubated
at 35◦C for 7 days before colony forming units (CFU) were
counted. A reduction in the CFU count of ≥99.9% relative to
the starting inoculum was considered fungicidal (Klepser et al.,
1998).
The growth kinetics of S. schenckii 4821 and S. brasiliensis 4823
in RPMI 1640 medium supplemented with 2% glucose and 0.165
M MOPS were determined on untreated controls and used to
calculate growth rate (µ) and generation time (g) according to the
equations: log10Nt – log10N0 = µ(t–t0)/2.303 and g = loge2/µ,
where N0 is number of cells at the start of the exponential phase,
Nt is number of cells at the stationary phase, t0 is the starting time
and t is the time when the culture reached the stationary phase
(Deacon, 2006).
Extraction and Separation of Neutral
Lipids
Total lipids of S. schenckii 4821 and S. brasiliensis 4823
yeast cells were extracted using the Folch method (Folch
et al., 1957). Briefly, 1 mL of extraction solution (chloroform-
methanol, 2:1, v/v) for each 1 g of dry extract were added
to a glass tube containing yeast untreated or treated for 96 h
with sub-inhibitory concentrations (MIC/2) of itraconazole or
H3. Samples were lysed mechanically with glass beads (10
cycles of vortex homogenization of 1 min with intervals of
1 min on ice). Suspensions were kept at 4◦C for 7 days,
and then filtered, concentrated, and suspended with 3 mL
of chloroform. Total lipids were applied to a silicic acid
column (1.5 cm × 4 cm) and neutral lipids were eluted
with four column volumes of chloroform and collected as a
single fraction. Solvent was evaporated in a rotary evaporator
under vacuum at 50◦C, and neutral lipids were suspended
and transferred into a 10-mL glass conical centrifuge tube.
Samples were dried under nitrogen to be subsequently analyzed
by gas chromatography (GC) with mass spectrometry (MS)
detection.
Free Sterol Analyses
For quantitative analysis and structural assignment, neutral lipids
were separated in a high-resolution capillary column (Ultra-2,
25 m × 0.20 mm i.d., with 5% phenyl-methylsiloxane and a
film thickness of 0.33 µm) in an Agilent Technologies 7890A
gas chromatograph equipped with a 5975C inert XL MSD mass
selective detector (Agilent Technologies, Inc. USA). Lipids were
dissolved in ethyl acetate and injected into the column at an
initial temperature of 50◦C (1 min), followed by a temperature
increase to 270◦C at a rate of 20◦C/min and a further increase
to 290◦C at a rate of 1◦C/min. The carrier gas (He) flow was
kept constant at 1 ml/min. Injector temperature was 250◦C
and the detector was kept at 280◦C. The total run time was
53 min. Mass spectra were obtained by electron ionization
(EI) at 70◦eV. The assignment of structures was based on
relative chromatographic behavior as well as on the characteristic
fragmentation patterns observed in MS and by comparison
of the mass spectra with those available in the NIST library
(http://www.nist.gov/nvl/).
Transmission Electron Microscopy
Sporothrix schenckii 4821 and S. brasiliensis 4823 yeast cells were
treated for 96 h with sub-inhibitory concentrations (MIC/2)
of itraconazole or H3, after which cells were washed in PBS,
fixed in 2.5% glutaraldehyde and 4% formaldehyde in 0.1 M
cacodylate buffer (pH 7.2) for 24 h at 4◦C, and then post-
fixed in 1% osmium tetroxide in 0.1 M cacodylate buffer
containing 1.25% potassium ferrocyanide and 5 mM CaCl2
for 2 h at 4◦C. Cells were washed, dehydrated in a series of
ethanol solutions of increasing concentration (30, 50, 70, 90,
100%, and ultra-dry ethanol) for 30 min at each step, and
then embedded in Spurr resin. Ultrathin sections were stained
in uranyl acetate and lead citrate and observed in a JEOL
1200 EX electron microscope (JEOL Ltd., Japan) equipped with
a CCD camera Megaview III (Soft Image System, Germany).
Images were acquired using iTEM software (Soft Image System,
Germany). ImageJ software (NIH, USA) was used to determine
the thickness of the inner cell wall (ICW) and of the outer
microfibrillar layer (ML) of the cell wall in 20 cells per
sample.
Scanning Electron Microscopy
Sporothrix schenckii 4821 and S. brasiliensis 4823 yeast cells
treated for 96 h with sub-inhibitory concentrations (MIC/2)
of itraconazole or H3 were fixed as described above (see
“Transmission Electron Microscopy”), after which 100-µL
aliquots of each sample were adhered to poly-L-lysine-coated
glass coverslips, post-fixed with 1% osmium tetroxide in 0.1
M cacodylate buffer containing 1.25% potassium ferrocyanide,
dehydrated in a graded ethanol series, critical-point-dried in
CO2, and coated with gold. Images were obtained in a FEI Quanta
250 scanning electron microscope (FEI Company, USA). In order
to determine cell size, mean Feret diameter (distance between two
parallel lines tangent to the 2D projection of a 3D object) was
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TABLE 1 | Antifungal activity of 24-SMT inhibitor H3 and itraconazole against Sporothrix schenckii and Sporothrix brasiliensis.
Filamentous form Yeast form
Species Compound MIC rangea MIC modeb MFC rangec MFC moded MIC rangea MIC modeb MFC rangec MFC moded
S. schenckii H3 0.01–0.5 0.25 0.03–8 1 0.03–0.25 0.125 0.06–8 0.25
(n = 16) Itraconazole 0.06–1 0.5 0.06 – >16 >16 0.06–1 0.5 0.25 – >16 0.5
S. brasiliensis H3 0.03–0.5 0.25 0.25 – >16 8 0.01–0.25 0.125 0.03–16 0.125
(n = 16) Itraconazole 0.25 – > 16 4 0.25 – >16 >16 0.25–4 0.5 0.25– >16 0.5
All values are expressed in mg/L. aRange of MIC values (range of lowest drug concentrations that prevents fungal growth relative to untreated controls) for the different
fungal strains tested. bMode of MIC values (MIC values that occur most frequently). cRange of MFC values (range of lowest drug concentrations that produced no fungal
growth) for the fungal isolates tested. dMode of MFC values (MFC values that occur most frequently).
calculated for 50 yeast-like cells using Image J software (NHI,
USA). Shapes of yeast-like cells were determined according aspect
ratio (ratio between maximum and minimum Feret diameters),
wherein values closer to 1 indicate a globose/oval morphology
and values much higher or lower than 1 indicate an elongated
morphology.
Flow Cytometry Analysis
Sporothrix schenckii 4821 and S. brasiliensis 4823 yeast cells
treated for 96 h with sub-inhibitory concentrations (MIC/2)
of itraconazole or H3 (106 cells/mL) were washed in PBS
and incubated with 10 µM of MitoTrackerr Red CMXRos
(Molecular ProbesTM, USA) for 30 min at room temperature in
the dark, after which the cells were washed in PBS, fixed in 1%
formaldehyde in PBS and washed again. Samples were analyzed
in a BD AccuriTM C6 flow cytometer (BD Biosciences, USA)
that counted 2000 events per sample, and data were analyzed
using BD Accuri C6 software. Results are representative of three
independent experiments. MitoTrackerr Red CMXRos stains
mitochondria in live cells, and its accumulation is dependent
upon membrane potential.
Drug Interaction Assay
A checkerboard microdilution method (Pillai et al., 2005) was
used to examine interactions between itraconazole and H3, using
four isolates from each species in the yeast form. Itraconazole
and H3 were tested at concentrations of 0.06–4 mg/L and 0.03–
0.5 mg/L (in serial 1:2 dilutions), respectively, against final yeast
concentrations of 0.5–2.5 × 103 CFU/mL at 35◦C for 5 days.
Antifungal combinations were classified according the fractional
inhibitory concentration index (FICI), defined by the equation:
FICI = (MICa in combination/MICa tested alone) + (MICb
in combination/MICb tested alone), where “a” was itraconazole
and “b” was H3 (Pillai et al., 2005). Interactions were considered
synergistic if FICI ≤ 0.5, absent if FICI >0.5 and ≤ 4, and
antagonistic if FICI >4 (Odds, 2003).
Drug Selectivity Toward Fungal Cells
To evaluate the selectivity of H3 toward S. schenckii and
S. brasiliensis, the concentration of this compound that elicited
50% cytotoxicity (CC50) toward monkey cell line LLC-MK2
cells or 50% hemolysis (HA50) of human red blood cells was
estimated as described previously (Ishida et al., 2006). Selectivity
indexes were calculated according to the formula: SI = CC50 or
HA50/median MIC. For comparison with H3, we also determined
CC50 and HA50 values for itraconazole in parallel.
Statistical Analysis
Statistical analysis was performed using Prism 5.0 (GraphPad
Software, Inc., La Jolla, CA, USA), and statistical significance was
accepted when p < 0.05. The Mann–Whitney test was used to
analyze differences between antifungal treatments. Differences in
cell size and in the thickness of cell wall components between
untreated and treated yeast cells were analyzed by one-way
ANOVA (Dunnett’s test).
RESULTS
The 24-SMT Inhibitor H3 is more
Effective than is Itraconazole against
S. schenckii and S. brasiliensis
To evaluate the sensitivity of S. schenckii and S. brasiliensis isolates
to the 24-SMT inhibitor H3 (a sterol hydrazone analog), the MIC
and MFC of H3 and of itraconazole were determined in vitro
for filamentous and yeast forms. The observed MICs of H3
were lower than those of itraconazole (p < 0.0001), as were its
MFC mode values, indicating that H3 was the more effective
compound against both species (Table 1). Itraconazole was less
effective against S. brasiliensis than it was against S. schenckii
(p = 0.0015 and 0.008 for the filamentous and yeast forms,
respectively).
H3 has Fungistatic Activity against
S. schenckii and S. brasiliensis
To determine whether the activity of H3 on S. schenckii and
S. brasiliensis was fungicidal or fungistatic, we performed time-
kill assays using S. schenckii 4821 and S. brasiliensis 4823 isolates
(Figure 2). Time-kill assays for itraconazole were performed
in parallel (Figure 2). H3 had fungistatic activity against both
isolates. For S. schenckii 4821, the inhibitory activity of H3 was
stronger than that of itraconazole: after 168 h, there was a 2 Log10
reduction in yeast viability for H3 at 4xMIC, compared with a
reduction of 1 Log10 for itraconazole at 8xMIC. For S. brasiliensis
4823, the inhibitory activity of H3 was slightly stronger than that
of itraconazole, with a reduction in yeast viability of 1 Log10 for
H3 at 8xMIC.
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FIGURE 2 | Time-kill plots showing activity of the 24-SMT inhibitor H3 in comparison with that of itraconazole against the yeast forms of Sporothrix
schenckii ATCC MYA 4821 and S. brasiliensis ATCC MYA 4823. Data are displayed as mean and standard error of the mean and are representative of two
independent experiments made in duplicate.
Growth curve data (Figure 2, untreated samples) indicate that
both species reached the stationary phase after 96 h of growth at
35◦C, with a generation time (g) of 7 h and 27 min and a growth
rate (µ) of 0.093/h. Therefore, this time-point was chosen for
treatment with H3 or itraconazole in the subsequent experiments.
Sterols Found in S. schenckii and
S. brasiliensis
The free sterol composition of S. schenckii and S. brasiliensis
as measured by high-resolution capillary gas chromatography
coupled to mass spectrometry (GC-MS) is presented here in
detail for the first time in the literature (Table 2). Although
ergosterol was the major sterol, representing over 83% of the
total amount of sterols, some more unusual sterols were also
detected as minor sterol components in S. schenckii 4821 and
S. brasiliensis 4823, including: (i) ergosta-5,7,22,24(24′)-tetraen-
3β-ol; (ii) ergosta-5,7-dien-3β-ol/5-dehydro-episterol, which co-
eluted at 26.6 min; and (iii) stigmasterol (Table 2).
Inhibition of 24-SMT by H3 Leads to
Ergosterol Depletion in S. schenckii and
S. brasiliensis
Analyses of the free sterol composition of cells after treatment
with sub-inhibitory concentrations (MIC/2) of the 24-SMT
inhibitor H3 revealed that the sterols present in control cells
(ergosterol and precursors) were completely replaced by 14α-
methylated sterols. Both S. brasiliensis 4823 and S. schenckii
4821 accumulated mainly lanosterol (between 64.1 and 69.8%)
(Table 2), pointing to a significant perturbation of the C-
24 alkylation reaction corresponding to 24-SMT inhibition.
However, there were differences between the two species in
the extent to which other intermediates were accumulated.
The rate of accumulation of lanosta-8,24-dien-3-one was
30.2% in S. schenckii 4821 and 4.5% in S. brasiliensis 4823,
which also accumulated two other intermediates not found
in S. schenckii 4821: 14α-methyl-ergosta-8,24(24′)-dien-3β-ol
(24.1%) and 14α-methyl-cholesta-8-en-3-one (7.3%) (Table 2).
The accumulation of 3-ketosteroids (14α-Methyl-5α-cholesta-8-
en-3-one and lanosta-8,24-dien-3-one) indicates that H3 also
interferes directly or indirectly with the NADPH-dependent 3-
ketosteroid reductase.
Itraconazole does not Completely Block
Ergosterol Synthesis in S. schenckii and
S. brasiliensis
Itraconazole only partially inhibited ergosterol synthesis
(∼63%) but completely arrested synthesis of other sterols
(ergosta-5,7,22,24(24′)-tetraen-3β-ol, ergosta-5,7,dien-3β-ol/5-
dehydro-episterol, and stigmasterol) which were found in
control cells (Table 2). Likewise, sterol analysis revealed that
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TABLE 2 | Free sterols present in Sporothrix schenckii ATCC MYA 4821 and Sporothrix brasilensis ATCC MYA 4823 growth in untreated (control) and
treated with H3 o itraconazole.
Sporothrix schenckii Sporothrix brasiliensis
Sterol Retention Time in (min) Control H3 Itraconazol Control H3 Itraconazol
14α-Methyl-5α-cholesta-8-en-3-one (1)∗ 24.4 – – – – 7.3 –
Ergosterol (2)∗ 25.5 83.1 – 31.2 92.1 – 33.7
14α-Methyl-5α-ergosta-8,24(24′)-dien-3β-ol (3)∗ 25.8 – – 3.1 – 24.1 4.8
Ergosta-5,7,22,24(24′)-tetraen-3β-ol (4)∗ 25.9 3.9 – – – – –
Ergosta-5,7,dien-3β-ol (5)/5-Dehydro-episterol (6)∗ 26.6 7.7 – – 4.7 – –
4,14-Dimethyl-ergosta-5,7-24(24′)-trien-3β-ol (7)∗ 26.7 – – 4.5 – – 3.3
Stigmasterol (8)∗ 27.2 5.2 – – 3.2 – –
Obtusifoliol (9)∗ 27.3 – – 15.6 – – 21.5
Lanosta-8,24-dien-3-one (10)∗ 27.6 – 30.1 10.0 – 4.5 6.0
Lanosterol (11)∗ 28.4 – 69.8 – – 64.1 –
24-Methylene-lanosta-8-en-3-one (12)∗ 29.2 – – 4.4 – – –
Eburicol (13)∗ 30.0 – – 17.4 – – 20.1
24-Ethyl-lanosta-8,22-dien-3β-ol (14)∗ 32.3 – – 2.1 – – –
(E)24-ethylidenelanost-8-en-3β-ol (15)∗ 32.8 – – 4.1 – – 3.8
(Z)24-ethylidenelanost-8-en-3β-ol (16)∗ 33.3 – – 7.4 – – 6.7
∗Numbers in parenthesis correspond to the numbers used in the schematic model Figure 6.
both itraconazole treated isolates accumulated nine 14α-
methyl sterols: (i) obtusifoliol, (ii) lanosta-8,24-dien-3-one, (iii)
eburicol, (iv) 14α-methyl-ergosta-8,24(28)-dien-3β-o, (v) 4,14-
dimethyl-ergosta-5,7-24(28)-trien-3β-ol, (vi) 24-methylene-
lanosta-8-en-3-one, (vii) 24-ethyl-lanosta-8,22-dien-3β-ol, (viii)
24(E)-ethylidenelanosta-8-en-3β-ol, and (ix) 24(Z)-ethylidenela-
nosta-8-en-3β-ol (Table 2).
Inhibition of 24-SMT Changes the
Morphology of S. schenckii and
S. brasiliensis
To determine the effect of 24-SMT inhibition on cell morphology,
S. schenckii 4821 and S. brasiliensis 4823 yeast cells were
analyzed by scanning and transmission electron microscopy
(SEM and TEM, respectively) after treatment with sub-inhibitory
concentrations (MIC/2) of H3 for 96 h (Figures 3 and 4). The
same cells treated with itraconazole were similarly analyzed.
SEM analysis revealed that untreated yeast cells of both isolates
had an elongated shape (aspect ratio medians were 1.83 and 1.70
for S. schenckii 4821 and S. brasiliensis 4823 cells, respectively)
(Figures 3A and 4A). Measurement of Feret diameters revealed
that S. schenckii 4821 yeast cells were larger than those from
S. brasiliensis 4823 (p = 0.048). Yeast-hyphae conversion was
observed in S. schenckii 4821 control and itraconazole treated
cultures but not in H3 treated cultures (Figures 3A,D,G). In
addition, we observed an increase in cell size (p < 0.001,
Figure 4J) after treatment of S. schenckii with H3 and a decrease
in cell size after itraconazole treatment (p < 0.001, Figure 4J). In
contrast, treatment of S. brasiliensis 4823 with itraconazole led to
an increase in cell size (p< 0.0001, Figure 4J).
TEM images of untreated S. schenckii 4821 (Figures 3B and
4C) and S. brasiliensis 4823 (Figures 4B,C) cells revealed an
electron-dense cytoplasm containing mitochondria and a nucleus
surrounded by a cell membrane and a cell wall with a clear inner
layer (ICW) and a compact microfibrillar outer layer (ML). The
outer layer was thicker in S. brasiliensis 4823 than in S. schenckii
4821 (p= 0.017).
Sporothrix schenckii 4821 cells treated with H3 showed
reduced cytoplasmic electron-density (Figure 3E), while
itraconazole treatment promoted accumulation of electron-
dense vacuoles next to the Golgi complex and electron-lucent
vacuoles in the cytoplasm (Figure 3H) while also inducing
grooves in the cell wall (arrow in Figure 3I). No statistically
significant differences in the thickness of cell wall components
were detected between control and treated cells (Figure 3K).
Treatment of S. brasiliensis 4823 cells with H3 decreased
ML thickness (p < 0.001) (Figure 4K) but did not result
in clear changes in cytoplasmic ultrastructure (Figures 4E,F).
However, treatment with itraconazole reduced cytoplasmic
electron-density in S. brasiliensis 4823 and was associated with
the presence of small vesicles next to the plasma membrane
(Figures 4H,I, arrows) and with decreased ML thickness
(p< 0.001) (Figure 4K).
Inhibition of 24-SMT Induces
Mitochondrial Disturbances in
S. schenckii and S. brasiliensis
Mitochondria play a central role in maintaining homeostasis
of the cell. Mitochondrial activity was evaluated after
exposure to H3 or to itraconazole by MitoTracker Redr
CMXRos stain and flow cytometry (Figure 5). H3 exposure
promoted mitochondrial disturbances in both isolates,
as demonstrated by the increase (S. schenckii 4821) and
decrease (S. brasiliensis 4823) in MitoTracker Red CMXRos
fluorescence intensity of stained cell populations (p < 0.05)
(Figure 5). In contrast, no statistically significant change in
mitochondrial activity was observed after itraconazole exposure
(Figure 5).
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FIGURE 3 | Ultrastructural analysis of Sporothrix schenckii ATCC MYA 4821 yeast cells treated with 0.125 mg/L H3 (D–F) or 0.25 mg/L itraconazole
(G–I) (MIC/2) compared to untreated cells (A–C). Scanning electron microscopy (A,D,G) and transmission electron microscopy (B,C,E,F,H,I) images show the
presence of: m, mitochondria (B); n, nucleus (B); G, Golgi complex (H); inner cell wall (ICW); microfibrillar cell wall layer (ML). The arrowhead in (I) indicates a groove
in the cell wall structure. (J) Cell diameter analysis by calculation of Feret diameters. (K) Analysis of ICW and ML thickness as measured in TEM images.
∗∗p < 0.001; ∗∗∗p < 0.0001. Scale bars: 5 µm (A,D,G); 0.5 µm (B,E,H); 0.2 µm (C,F,I).
H3 Increases the Effectiveness of
Itraconazole against S. schenckii and
S. brasiliensis
In view of the high effectiveness of H3, we decided to test whether
H3 could improve itraconazole activity. Thus, checkerboard
microdilution assays were performed using the yeast forms of
four isolates from each species in order to determine whether
itraconazole and H3 act synergistically. Co-incubation led to a
reduction in the itraconazole MIC for all tested strains (Table 3).
However, the interaction between H3 and itraconazole was
considered synergistic only for the S. brasiliensis strains 4823 and
Ss 37 (FICI= 0.5 and 0.27, respectively).
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FIGURE 4 | Ultrastructural analysis of Sporothrix brasiliensis ATCC MYA 4823 cells after exposure to 0.03 mg/L H3 (D–F) or 0.25 mg/L itraconazole
(G–I) compared to untreated cells (A–C). Scanning electron microscopy (A,D,G) and transmission electron microscopy (B,C,E,F,H,I) images show the presence
of: m, mitochondria (B); n, nucleus (B,H); v, vacuole (B); inner cell wall (ICW); microfibrillar cell wall layer (ML). Arrowheads indicate small vesicles associated with the
plasma membrane (I). (J) Cell diameter analysis by calculation of Feret diameters. (K) Analysis of ICW and ML thickness as measured in TEM images. ∗p < 0.05,
∗∗p < 0.001, ∗∗∗p < 0.0001. Scale bars: 5 µm (A,D,G); 0.5 µm (B,E,H); 0.2 µm (C,F,I).
H3 Exhibits Great Selectivity toward
S. schenckii and S. brasiliensis
To estimate the selectivity of H3 toward S. schenckii and
S. brasiliensis, we determined the cytotoxic effect of this
compound (and also of itraconazole) in LLC-MK2 cells
(CC50) as well as their hemolytic activity (HA50) (Table 4).
The CC50 of H3 was similar to that of itraconazole. No
hemolytic effect toward red blood cells was observed for
either of the tested drugs at concentrations up to 100 mg/L.
Analysis of the selectivity index (CC50 or HA50/median MIC)
revealed that H3 was at least 666 times more selective
toward both yeast and filamentous forms of S. schenckii and
S. brasiliensis than it was toward LLC-MK2 and red blood cells
(Table 4).
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FIGURE 5 | Mitochondrial activity after treatment of Sporothrix
schenckii ATCC MYA 4821 and S. brasiliensis ATCC MYA 4823 yeast
cells with H3 or itraconazole. Cells untreated or treated for 96 h with
sub-inhibitory concentrations of H3 or itraconazole were stained with
MitoTracker Red CMXRos, after which fluorescence intensity was analyzed by
flow cytometry. H3 exposure induced a statistically significant fluorescence
intensity increase (S. schenckii 4821) or decrease (S. brasiliensis 4823),
reflecting mitochondrial disturbance (∗p < 0.05).
DISCUSSION
We investigated the effect of the 24-SMT inhibitor H3 (a
sterol hydrazone analog) on the sterol biosynthesis pathway in
S. schenckii and S. brasiliensis. We found that H3 was more
effective than was itraconazole (currently the first choice for
treatment of sporotrichosis) in arresting the growth of Sporothrix
sp. The H3 MICs obtained for S. schenckii and S. brasiliensis
(MIC mode ≤ 0.25 mg/L; Table 1) were similar to those
previously reported for P. brasiliensis (1 µM, corresponding to
0.4 mg/L) (Visbal et al., 2011). In contrast, H3 has been reported
to be less active against some pathogenic yeasts, including
Candida albicans, Candida parapsilosis, Cryptococcus neoformans
and Cryptococcus gattii (MIC values around 4 mg/L) (Vivas et al.,
2011).
In addition, the MIC and time-kill results showed that
itraconazole was less active in vitro against S. brasiliensis than
it was against S. schenckii, a surprising finding. This difference
in activity between species was not observed for H3 (Table 1;
Figure 2).
The sterol biosynthesis pathway in some fungi is well
established, and two main ergosterol biosynthesis pathways are
known (pathways A and B, Figure 6), but little is known about the
pathway of ergosterol biosynthesis in Sporothrix sp. Therefore,
the use of sterol biosynthesis inhibitors (such as those used here)
that lead to accumulation of sterol intermediates may reveal novel
metabolic pathways.
In its early stages, fungal ergosterol synthesis uses an
isoprenoid pathway to squalene oxide similar to the one involved
in cholesterol formation (Mercer, 1993; Nes, 2011). In most fungi,
the key transformations from lanosterol to ergosterol take place
in the following order: (i) introduction of a methyl group into
lanosterol at C-24, accompanied by a double-bond shift from
124(25) to 124(24
′ ) to yield eburicol; (ii) demethylation at C-
14 to yield a 4,4-dimethyl-18,14-sterol; (iii) saturation of the
-114 double bond introduced in the previous step to yield 4,4-
dimethyl-18-sterol; (iv) successive removal of the two methyl
groups at C-4 to yield fecosterol; (v) a double bond shift from 18
to 17 and introduction of a double bond at 15 to yield ergosta-
5,7,24(24′)-trien-3β-ol; (vi) introduction of a double bond at
122 to yield ergosta-5,7,22,24(24′)-tetraen-3β-ol; and reduction
of the 124(24′) double bond to yield ergosterol (pathway A,
Figure 6). Other fungi such as Saccharomyces cerevisiae and
C. albicans constitute important exceptions, in which lanosterol
is demethylated in the nucleus at C-4 and C-14 before C-24
alkylation of zymosterol (pathway B, Figure 6) (Song and Nes,
2007).
As is true for most pathogenic fungi, the major sterol detected
in S. schenckii and S. brasiliensis was ergosterol (Table 2).
Nevertheless, less usual sterols were also observed to a lesser
degree, including ergosta-5,7,22,24(24′)-tetraen-3β-ol, ergosta-
5,7-dien-3β-ol, 5-dehydro-episterol, and stigmasterol (Table 2).
An interesting finding was the identification of C-24 ethyl sterols
in S. brasiliensis that are more usual in plant cells, where they have
multiple roles related to plant cell growth and development (Nes
et al., 2006). However, few reports exist describing the detection
in fungi of 24-ethyl sterols, for which no role has been assigned
yet. Based on the results of the present study, we propose a
schematic model of sterol biosynthesis pathways in S. schenckii
and S. brasiliensis (Figure 6), showing the sites of action of the
studied inhibitors.
Sporothrix schenckii 4821 and S. brasiliensis 4823 grown
in the presence of itraconazole accumulated 14α-methylated
sterols (Table 2, see number 3, 7, 9, 10, 12, to 16),
which account for more than 60% of the total sterols.
Ergosterol is still detected and corresponds to about 30%
of total sterols. These results indicate that, at sub-inhibitory
concentrations, itraconazole only partially blocks ergosterol
synthesis. Accumulation of eburicol, obtusifoliol, and lanosta-
8,24-dien-3-one indicates that C14α-demethylase was inhibited.
The introduction of a methyl group into lanosterol at C-24,
accompanied by a double-bond shift from 124(25) to 124(24
′ )
to yield eburicol and obtusifoliol, strongly suggests that C-
24 alkylation occurs as the first step in the conversion of
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TABLE 3 | Associations of itraconazole and H3 against Sporothrix schenckii and Sporothrix brasiliensis yeast cells. Minimum inhibitory concentration
(MIC) values are in mg/L.
Species Fungal isolate MIC drugs tested alone MIC drugs in combination
H3 Itraconazole H3 Itraconazole FICIa
S. schenckii 4821 0.06 0.5 0.06 0.25 1.50
4820 0.25 0.5 0.06 0.25 0.74
Ss 03 0.25 0.25 0.125 0.125 1.00
Ss 42 0.125 0.25 0.125 0.03 0.74
S. brasiliensis 4823 0.06 0.5 0.03 0.03 0.50b
Ss 14 0.03 2.0 0.03 0.06 1.00
Ss 37 0.125 2.0 0.03 0.06 0.27b
Ss 69 0.06 0.5 0.06 0.25 1.50
aFractional inhibitory concentration index, FICI = (MICa in combination/MICa tested alone) + (MICb in combination/MICb tested alone), where a and b are itraconazole
and H3, respectively.
bSynergistic interactions (FICI ≤ 0.5).
TABLE 4 | Selectivity of 24-SMT inhibitor H3, compared to itraconazole, toward Sporothrix schenckii and Sporothrix brasiliensis yeast cells.
Compound Yeast MICa medians (mg/L) Cytotoxicity against LLC-MK2 cells Hemolytic activity against red blood cells
S. schenckii S. brasiliensis CC50b
(mg/L)
SIc
S. schenckii
SIc
S. brasiliensis
HA50d
(mg/L)
SIc
S. schenckii
SIc
S. brasiliensis
H3 0.15 0.1 100 666.7 1000 >100 >666.7 >1000
Itraconazole 0.39 1.17 >100 >256.4 >85.5 >100 >256.4 >85.5
aMinimum inhibitory concentration, b50% cytotoxic concentration, cSelective index: SI = CC50 or HA50/MIC medians, d50% hemolytic concentration.
lanosterol to ergosterol in these fungi (pathway A, Figure 6).
This result is consistent with a previous study on P. brasiliensis
(Visbal et al., 2011). Accumulation of lanosterol-8,24-dien-3-one,
24-methylene-lanosta-8-en-3-one, and eburicol may indicate
that the presence of a 14α-methyl group blocks the first
C4α-demethylation process. Although this blockage would not
be complete as shown by the biosynthesis of the sterols
4,14-dimethyl-ergosta-5,7-24(24′)-trien-3β-ol and obtusifoliol
(pathway C, Figure 6). The second C4α-demethylation process
seems to be more inhibited, based on the presence of
small amounts of 14α-methyl-5α-ergosta-8,24(24′)-dien-3β-ol
(pathway C, Figure 6). Another possibility is that itraconazole
inhibits not only C14α-demethylase but also NADPH-dependent
3-ketosteroid reductase, i.e., the enzyme catalyzing the last step
in the demethylation at C-4 (Vanden Bossche et al., 1993;
Marichal et al., 1999). This inhibition may occur directly or
indirectly.
Three other uncommon lanostane-type triterpenoids were
identified in fungi grown in the presence of itraconazole: 24(E)-
ethylidenelanosta-8-en-3β-ol, 24(Z)-ethylidenelanosta-8-en-3β-
ol, and 24-ethyl-lanosta-8,22-dien-3β-ol (Table 2). This data
indicates that lanosterol is not the only substrate of 24-SMT
(Kaneshiro et al., 1999b), as eburicol, which can accept a second
methyl group on the 124(24′)-bond (pathway D, Figure 6),
is also a substrate, albeit a poorer one. Previous reports of
these sterols from human-derived P. carinii (Kaneshiro et al.,
1999a,b; Amit and Kaneshiro, 2001) helped to assign the correct
configuration of the isomers Z and E on the side chain of
24(E)-ethylidenelanost-8-en-3β-ol and 24(Z)-ethylidenelanost-
8-en-3β-ol. The accumulation of 24-ethylsterols in Sporothrix sp.
exposed to itraconazole suggests that 24-SMT activities are very
high in these organisms.
In contrast, ergosterol synthesis was completely blocked in
S. schenckii and S. brasiliensis grown in the presence of the 24-
SMT inhibitor H3, resulting in a strong increase in the levels of
lanosterol (64–70%, Table 2). This result confirms that lanosterol
is first converted into eburicol by 24-SMT and then undergoes
C14α-demethylation (pathway A, Figure 6). Hence, we can
conclude that H3 inhibits fungal growth by interfering with 24-
SMT, as has been previously reported in P. brasiliensis (Visbal
et al., 2011).
Sporothrix brasiliensis treated with H3 also accumulated two
3-ketosteroids (14α-methyl-5α-cholesta-8-en-3-one and lanosta-
8,24-dien-3-one), suggesting that H3 allows the eburicol
biosynthesis followed by demethylation at C-4, with little
interference in the activity of NADPH-dependent 3-ketosteroid
reductase (pathway C, Figure 6). On the other hand, S. schenckii
accumulated a higher proportion of lanosta-8,24-dien-3-one
(pathway E, Figure 6), which indicates that the NADPH-
dependent 3-ketosteroid reductase of S. schenckii was more
susceptible to the action of H3. Accumulation of 3-ketosteroids
can contribute positively to the antifungal activity of H3
in Sporothrix sp. because these sterols have been shown to
destabilize the lipid bilayer and to inhibit the growth of
sterol-requiring mycoplasmas (Vanden Bossche et al., 1993;
Marichal et al., 1999). This combined effect completely blocks
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FIGURE 6 | Representative pathway of sterol biosynthesis in Sporothrix schenckii and Sporothrix brasiliensis, and sites of action of the studied
inhibitors. Sterols identified on Table 2 are shown in this figure: (1) 14α-methyl-cholesta-8-en-3-one, (2) ergosterol, (3) 14α-methyl-ergosta-8,24(24’)-dien-3β-ol,
(4) ergosta-5,7,22,24-tetra-en-3β-ol, (5) ergosta-5,7,24(24′)-trien-3β-ol, (6) 5-dehydro-episterol, (7) 4,14-dimethyl-ergosta-5,7,24(24’)-trien-3β-ol, (8) stigmasterol,
(9) obtusifoliol, (10) lanosta-8,24-dien-3-one, (11) lanosterol, (12) 24-methylene-lanosta-8-en-3-one, (13) eburicol, (14) 24-ethyl-lanosta-8,22-dien-3β-ol,
(15) 24(E)-ethylidenelanost-8-en-3β -ol, (16) 24(Z)-ethylidenelanost-8-en-3β-ol, (17) 4,4-dimethyl-ergosta-8,14,24(24′)-trien-3β-ol, (18)
4,4′-dimethyl-ergosta-8,24(24′)
-dien-3β-ol, (19) 4-methyl-ergosta-8,24(24′)-dien-3β-ol, (20) fecosterol, (21) 4,4-dimethyl-ergosta-8,14,24-trien-3β-ol, (22) 4,4-dimethyl-ergosta-8,24-dien-3β-ol,
(23) 4-methyl-ergosta-8,24-dien-3β-ol, and (24) zymosterol. Thick lines indicate the main pathways (pathway A or B) from lanosterol to ergosterol. Dashed arrows
show accumulation of intermediate sterols by action of the sterol biosynthesis inhibitors itraconazole and H3 (pathways C, D, E). Arrows marked with an ‘X’ indicate
inhibitory interactions of the sterol hydrazone H3 and itraconazole with 124-sterol methyl transferase (24-SMT1) and C14α-demethylase, respectively. 24-SMR,
124-sterol methyl reductase.
not only ergosterol synthesis but also that of 4,4-demethylated
14α-methylsterols. This is the first report of inhibition of
an NADPH-dependent 3-ketosteroid reductase by a sterol
hydrazone derivative.
It is likely that the first metabolic step in the 24-alkyl sterol
synthetic pathway of Sporothrix sp. involves C24-methylation of
lanosterol to yield eburicol, as has been described in studies of
the ergosterol pathway of the filamentous ascomycete Aspergillus
fumigatus (Alcazar-Fuoli et al., 2008) and of the basidiomycete
Cryptococcus neoformans (Nes et al., 2009; Nes, 2011). The 24-
SMTs of Sporothrix sp. were significantly more sensitive to the
action of H3 than to that of itraconazole. The former is associated
with a stronger antiproliferative effect by means of a complete
blockage of ergosterol biosynthesis.
SEM and TEM analyses corroborated MIC data showing
that S. schenckii yeast was more sensitive to the effects of
either of the two drugs (H3 and itraconzaole) when compared
to S. brasiliensis (Figures 3 and 4). Both treatments induced
different changes depending on the species. In S. schenckii 4821
treatment with H3 lead to an increased in cell size, alterations
in cell shape, and cytoplasmic electron-density reduction. In
contrast, S. brasiliensis 4823 only showed alteration in cell
wall thickness, with a normal cell size and shape. Alterations
in thickness of cell wall components was also observed after
treatment of C. albicans with other 24-SMT inhibitors (Ishida
et al., 2009). Considering itraconazole treatment, both species
also react in a different way. S. schenckii 4821, treatment induced
yeast filamentation, decreased in cell size and disarrangement of
cellular compartments (as Golgi complex and vacuoles) and cell
wall structure. On the other hand, S. brasiliensis 4823 exposure
to itraconazole showed an increase in cell size, reduction on
cytoplasmic electron-density and alteration in cell wall thickness.
Regarding to morphological alterations in S. schenckii and
S. brasiliensi, we can say that membrane plasmatic of these fungi
have special requirement for ergosterol, in order to maintain
both membrane integrity and fluidity, amounts others possible
functions. Therefore, compounds that could affect ergosterol
homeostasis like of H3 or itraconazole, may generate (i) loss
of these important physical characteristics, (ii) accumulation
of endogenous intermediates such as lanosterol or 14α-methy-
sterol. Both effects produce different and complex morphologies,
which are difficult to correlate at the first moment.
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Flow cytometry analyzes showed that H3 induced
mitochondrial disturbances in Sporothrix sp.; however, while
H3-treated S. schenckii 4821 cells showed an increased
fluorescence intensity when stained with MitoTracker Red
CMXRos; S. brasiliensis 4823 cells exhibited a decreased
fluorescence intensity to the same markers (Figure 5).
The accumulation of different ergosterol intermediates
that could be toxic themselves for the cells could help
to explain these differences observed between the two
species.
We also investigated whether concurrent treatment with H3
could enhance the antifungal effect of itraconazole, since they
inhibit different steps of the ergosterol biosynthesis pathway.
A checkerboard assay showed that the two antifungals had a
synergistic effect against the S. brasiliensis isolates 4823 and
Ss37, and that there was a reduction of itraconazole MICs
for all other tested isolates despite the lack of statistically
significant synergy (Table 3), showing that H3 can enhance
the anti-Sporothrix effectiveness of itraconazole. These results
suggest that treatment of sporotrichosis with a combination
of these two drugs may be of value. Synergistic effects
between H3 and another azole compound (posaconazole)
were previously reported in C. neoformans (Vivas et al.,
2011).
In addition, cytotoxicity assays revealed that H3 had
no hemolytic activity toward human red blood cells (at
concentrations of up to 100 mg/L) and had low cytotoxicity
toward LLCMK-2 cells (at a concentration of 100 mg/L)
(Table 4). The cytotoxicity results, combined with the high
sensitivity of S. schenckii and S. brasiliensis to H3, mean that
H3 has higher selectivity toward Sporothrix sp. than does
itraconazole.
The results of this preliminary study showing the effects of
H3 in vitro indicate that this molecule can potentially be used
for the development of improved treatments for sporotrichosis.
More studies should be conducted to confirm the activity of this
drug in vivo.
In summary, inhibition of 124-sterol methyltransferase (24-
SMT) by the sterol hydrazone analog H3 was an effective
antifungal strategy against S. schenckii and S. brasiliensis,
being more potent than itraconazole in inhibiting ergosterol
synthesis. H3 was also more selective toward fungal cells than
was itraconazole, and was able to enhance the anti-Sporothrix
effectiveness of itraconazole when used in conjunction with that
drug. Inhibition of the methylation reaction catalyzed by 24-SMT
has a strong antiproliferative effect via disruption of ergosterol
homeostasis, suggesting that this enzyme is a promising target
for novel antifungal therapies against sporotrichosis, either as sole
treatments or in combination with itraconazole.
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